Valion Bio, Inc.
VBIO
Positions held
Your positionsVBIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $1.96M | Enterprise value | $17.26M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.09 | Beta | 1.80 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 196.5% |
| Profit margin | 0.0% | ROE | -4.6% | ROA | -57.1% | Debt / equity | 4.10 |
| Current ratio | 1.11 | Free cash flow | -$8.06M | Analyst recommendation | none | Mean target | — |
| 52w high | $76.50 | 52w low | $2.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | -$0.3M | $0.1M | $0.0M | — |
| Op margin | — | — | 654.0% | -1700.7% | — | — |
| Net income | -$7.1M | -$6.2M | -$2.8M | -$2.6M | -$1.9M | — |
| Gross margin | — | — | — | -99.3% | — | — |
| Gross profit | — | — | — | -$0.1M | $0.1M | $0.1M |
| Operating income | -$6.4M | -$5.6M | -$2.0M | -$2.5M | -$1.7M | — |
- Operating margin expanded to 654%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $1.2M | $1.8M | — |
| Op margin | — | — | -701.1% | -548.8% | — |
| Net income | -$8.9M | -$5.7M | -$8.2M | -$10.1M | — |
| Gross margin | — | — | 24.4% | 16.3% | — |
| Gross profit | — | $0.0M | $0.3M | $0.3M | -$0.0M |
| Operating income | -$7.9M | -$4.5M | -$8.2M | -$10.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
2026-09-30 · BC-Most Active Stocks
2026-09-23 · Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
2026-09-22 · Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
2026-09-01 · Valion Bio Announces Changes to Management and Board of Directors
2026-08-27 · Valion Bio Announces Reverse Stock Split
2026-08-24 · BC-Most Active Stocks
2026-08-14 · BC-Most Active Stocks
2026-08-13 · Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
2026-08-13 · Top Premarket Decliners
2026-08-12 · BC-Most Active Stocks
Price (daily)
Full chart · RSI · MACD · patterns